Kezar Life Sciences (KZR) Accumulated Depreciation (2021 - 2024)
Historic Accumulated Depreciation for Kezar Life Sciences (KZR) over the last 4 years, with Q3 2024 value amounting to $6.2 million.
- Kezar Life Sciences' Accumulated Depreciation rose 2064.2% to $6.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.2 million, marking a year-over-year increase of 2064.2%. This contributed to the annual value of $5.4 million for FY2023, which is 1777.49% up from last year.
- Per Kezar Life Sciences' latest filing, its Accumulated Depreciation stood at $6.2 million for Q3 2024, which was up 2064.2% from $5.9 million recorded in Q2 2024.
- In the past 5 years, Kezar Life Sciences' Accumulated Depreciation registered a high of $6.2 million during Q3 2024, and its lowest value of $3.0 million during Q1 2021.
- For the 4-year period, Kezar Life Sciences' Accumulated Depreciation averaged around $4.6 million, with its median value being $4.6 million (2022).
- In the last 5 years, Kezar Life Sciences' Accumulated Depreciation surged by 3124.79% in 2022 and then skyrocketed by 1642.13% in 2023.
- Kezar Life Sciences' Accumulated Depreciation (Quarter) stood at $3.7 million in 2021, then increased by 26.01% to $4.6 million in 2022, then increased by 17.77% to $5.4 million in 2023, then increased by 14.41% to $6.2 million in 2024.
- Its last three reported values are $6.2 million in Q3 2024, $5.9 million for Q2 2024, and $5.7 million during Q1 2024.